Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × talactoferrin alfa × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 131 Radiotherapy 93 Carboplatin 82 Fluorouracil 78 Paclitaxel 77 Cyclophosphamide 76 Gemcitabine 70 Capecitabine 65 Docetaxel 64 Oxaliplatin 58 Doxorubicin 58 Etoposide 56 Leucovorin 49 Vincristine 45 Chemotherapy, Adjuvant 42 Cytarabine 38 Dexamethasone 35 Drug Therapy 33 Bevacizumab 30 Epirubicin 29 Pemetrexed 28 Neoadjuvant Therapy 25 Irinotecan 25 Tamoxifen 24 Prednisone 23 Methotrexate 21 Radiotherapy, Intensity-Modulated 20 Rituximab 19 Melphalan 19 Vinorelbine 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00706862 2012-03-15

FORTIS-C

Agennix

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡